Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD in Virology from the University of Hohenheim, Germany. He has held adjunct professorships at universities in Belgium and Germany. After his Academy career, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to perform various roles in vaccine R&D as well as late vaccine development. Geert then joined the Global Health Discovery team at the Bill & Melinda Gates Foundation in Seattle (USA) as Senior Program Director; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Manager of the Ebola Program. At GAVI, he followed efforts to develop an Ebola vaccine. He also represented GAVI in forums with other partners, including the WHO, to review progress in the fight against Ebola and develop global pandemic preparedness plans. In 2015, Geert examined and questioned the safety of the Ebola vaccine that was used in ring vaccination trials carried out by the WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Infection Research Center in Cologne as Head of the Vaccine Development Office. He is currently serving primarily as a biotechnology/vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.